Automating Predictive Phage Therapy Pharmacology

被引:2
|
作者
Abedon, Stephen T. [1 ]
机构
[1] Ohio State Univ, Dept Microbiol, Mansfield, OH 44906 USA
来源
ANTIBIOTICS-BASEL | 2023年 / 12卷 / 09期
关键词
active treatment; bacteriophage therapy; biocontrol; biological control; !text type='Java']Java[!/text]Script; MOI; passive treatment; pharmacodynamics; BACTERIOPHAGE THERAPY; GROWTH; POPULATION; ADSORPTION; INFECTION; DYNAMICS; HOST; EFFICIENCY; SYNERGY; SYSTEM;
D O I
10.3390/antibiotics12091423
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Viruses that infect as well as often kill bacteria are called bacteriophages, or phages. Because of their ability to act bactericidally, phages increasingly are being employed clinically as antibacterial agents, an infection-fighting strategy that has been in practice now for over one hundred years. As with antibacterial agents generally, the development as well as practice of this phage therapy can be aided via the application of various quantitative frameworks. Therefore, reviewed here are considerations of phage multiplicity of infection, bacterial likelihood of becoming adsorbed as a function of phage titers, bacterial susceptibility to phages also as a function of phage titers, and the use of Poisson distributions to predict phage impacts on bacteria. Considered in addition is the use of simulations that can take into account both phage and bacterial replication. These various approaches can be automated, i.e., by employing a number of online-available apps provided by the author, the use of which this review emphasizes. In short, the practice of phage therapy can be aided by various mathematical approaches whose implementation can be eased via online automation.
引用
收藏
页数:24
相关论文
共 50 条
  • [41] Mastitis therapy and pharmacology
    Erskine, RJ
    Wagner, S
    DeGraves, FJ
    VETERINARY CLINICS OF NORTH AMERICA-FOOD ANIMAL PRACTICE, 2003, 19 (01) : 109 - +
  • [42] Cough: Pharmacology and therapy
    Widdicombe, J
    Chung, F
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2002, 15 (03) : 185 - 186
  • [43] PHARMACOLOGY AND THERAPY OF STRESS
    OOMS, LAA
    RECUEIL DE MEDECINE VETERINAIRE, 1988, 164 (10) : 871 - 873
  • [44] PHARMACOLOGY AND OCULAR THERAPY
    JEGOU, JP
    RECUEIL DE MEDECINE VETERINAIRE, 1989, 165 (03) : 327 - 347
  • [45] PHARMACOLOGY AND PHYSICAL THERAPY
    ROTHSTEIN, JM
    PHYSICAL THERAPY, 1995, 75 (05): : 341 - 341
  • [46] Phage-specific antibodies: are they a hurdle for the success of phage therapy?
    Washizaki, Ayaka
    Sakiyama, Arata
    Ando, Hiroki
    ESSAYS IN BIOCHEMISTRY, 2024,
  • [47] Phage as a Modulator of Immune Responses: Practical Implications for Phage Therapy
    Gorski, Andrzej
    Miedzybrodzki, Ryszard
    Borysowski, Jan
    Dabrowska, Krystyna
    Wierzbicki, Piotr
    Ohams, Monika
    Korczak-Kowalska, Grazyna
    Olszowska-Zaremba, Natasza
    Lusiak-Szelachowska, Marzena
    Klak, Marlena
    Jonczyk, Ewa
    Kaniuga, Ewelina
    Golas, Aneta
    Purchla, Sylwia
    Weber-Dabrowska, Beata
    Letkiewicz, Slawomir
    Fortuna, Wojciech
    Szufnarowski, Krzysztof
    Pawelczyk, Zdzislaw
    Rogoz, Pawel
    Klosowska, Danuta
    ADVANCES IN VIRUS RESEARCH, VOL 83: BACTERIOPHAGES, PT B, 2012, 83 : 41 - 71
  • [48] European regulatory aspects of phage therapy: magistral phage preparations
    Verbeken, Gilbert
    Pirnay, Jean-Paul
    CURRENT OPINION IN VIROLOGY, 2022, 52 : 24 - 29
  • [49] Toward phage therapy for tuberculosis
    Le Bras, Alexandra
    LAB ANIMAL, 2024, 53 (04) : 87 - 87
  • [50] Phage therapy for Pseudomonas aeruginosa
    Devi, Sharmila
    LANCET INFECTIOUS DISEASES, 2023, 23 (10): : E408 - E408